Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Sep;81(3):390–395. doi: 10.1111/j.1365-2249.1990.tb05344.x

Cytotoxic T cells against herpes simplex virus in Behçet's disease.

K Hamzaoui 1, A Kahan 1, K Ayed 1, M Hamza 1
PMCID: PMC1534992  PMID: 2168823

Abstract

Lymphocytes from 36 patients with Behçet's disease (20 in remission and 16 in active phase) were stimulated in vitro with herpes simplex virus and then tested for their ability to generate cytotoxic T cell responses to the virus. Significant cytotoxic responses were found. CD4+ and CD8+ subpopulations from the patients in remission generated specific cytotoxic activity against autologous target cells. These observations suggested that CD4+ and CD8+ cytotoxic T cells may have an important host response in herpes virus infection in Behçet's disease.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J., Byrne J. A., Schreiber R., Patterson S., Oldstone M. B. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties. J Virol. 1985 Feb;53(2):552–560. doi: 10.1128/jvi.53.2.552-560.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bacon T. H., Ozbakir F., Elms C. A., Denman A. M. Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol. 1984 Sep;57(3):541–547. [PMC free article] [PubMed] [Google Scholar]
  3. Biddison W. E., Rao P. E., Talle M. A., Goldstein G., Shaw S. Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens. J Exp Med. 1982 Oct 1;156(4):1065–1076. doi: 10.1084/jem.156.4.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bourgault I., Gomez A., Gomard E., Picard F., Levy J. P., Gomrad E. A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines. J Immunol. 1989 Jan 1;142(1):252–256. [PubMed] [Google Scholar]
  5. Denman A. M., Fialkow P. J., Pelton B. K., Salo A. C., Appleford D. J., Gilchrist C. Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol. 1980 Oct;42(1):175–185. [PMC free article] [PubMed] [Google Scholar]
  6. Diaz P. S., Smith S., Hunter E., Arvin A. M. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Immunol. 1989 Jan 15;142(2):636–641. [PubMed] [Google Scholar]
  7. Eglin R. P., Lehner T., Subak-Sharpe J. H. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers. Lancet. 1982 Dec 18;2(8312):1356–1361. doi: 10.1016/s0140-6736(82)91268-5. [DOI] [PubMed] [Google Scholar]
  8. Fujii N., Minagawa T., Nakane A., Kato F., Ohno S. Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease. J Immunol. 1983 Apr;130(4):1683–1686. [PubMed] [Google Scholar]
  9. Hamza M., Ayed K., Hamzaoui K., Bardi R. Behçet's disease and major histocompatibility complex class II antigens in Tunisians. Dis Markers. 1988 Oct-Dec;6(4):263–267. [PubMed] [Google Scholar]
  10. Hamzaoui K., Ayed K., Hamza M., Touraine J. L. Natural killer cells in Behçet's disease. Clin Exp Immunol. 1988 Jan;71(1):126–131. [PMC free article] [PubMed] [Google Scholar]
  11. Hamzaoui K., Ayed K., Slim A., Hamza M., Touraine J. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol. 1990 Jan;79(1):28–34. doi: 10.1111/j.1365-2249.1990.tb05122.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jacobson S., Flerlage M. L., McFarland H. F. Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis. J Exp Med. 1985 Sep 1;162(3):839–850. doi: 10.1084/jem.162.3.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaplan D. R., Griffith R., Braciale V. L., Braciale T. J. Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products. Cell Immunol. 1984 Oct 1;88(1):193–206. doi: 10.1016/0008-8749(84)90064-9. [DOI] [PubMed] [Google Scholar]
  14. Meuer S. C., Hodgdon J. C., Cooper D. A., Hussey R. E., Fitzgerald K. A., Schlossman S. F., Reinherz E. L. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. J Immunol. 1983 Jul;131(1):186–190. [PubMed] [Google Scholar]
  15. Ohno S., Kato F., Matsuda H., Fujii N., Minagawa T. Detection of gamma interferon in the sera of patients with Behçet's disease. Infect Immun. 1982 Apr;36(1):202–208. doi: 10.1128/iai.36.1.202-208.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Peden K., Mounts P., Hayward G. S. Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probe. Cell. 1982 Nov;31(1):71–80. doi: 10.1016/0092-8674(82)90406-8. [DOI] [PubMed] [Google Scholar]
  17. Schmid D. S. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex. J Immunol. 1988 May 15;140(10):3610–3616. [PubMed] [Google Scholar]
  18. Sterkers G., Michon J., Henin Y., Gomard E., Hannoun C., Lévy J. P. Fine specificity analysis of human influenza-specific cloned cell lines. Cell Immunol. 1985 Sep;94(2):394–405. doi: 10.1016/0008-8749(85)90263-1. [DOI] [PubMed] [Google Scholar]
  19. Torpey D. J., 3rd, Lindsley M. D., Rinaldo C. R., Jr HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. J Immunol. 1989 Feb 15;142(4):1325–1332. [PubMed] [Google Scholar]
  20. Tsutsumi H., Bernstein J. M., Riepenhoff-Talty M., Cohen E., Orsini F., Ogra P. L. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses. Clin Exp Immunol. 1986 Dec;66(3):507–515. [PMC free article] [PubMed] [Google Scholar]
  21. Yasukawa M., Inatsuki A., Kobayashi Y. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells. J Immunol. 1989 Sep 15;143(6):2051–2057. [PubMed] [Google Scholar]
  22. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol. 1984 Jul;133(1):422–427. [PubMed] [Google Scholar]
  23. Young C., Lehner T., Barnes C. G. CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease. Clin Exp Immunol. 1988 Jul;73(1):6–10. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES